Brasil | Otros

Effect of treatment with a new nitric oxide donor, a hybrid derived from resveratrol and furoxan (E)-4-(4-(4-methoxystyryl)phenoxy)-3-methyl-1,2,5-oxadiazole-2-oxide, on priapism in sickle cell mouse and nitric oxide-deficient mouse

dc.contributorUniversidade Estadual de Campinas (UNICAMP)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2019-10-04T12:40:57Z
dc.date.accessioned2022-12-19T18:14:24Z
dc.date.available2019-10-04T12:40:57Z
dc.date.available2022-12-19T18:14:24Z
dc.date.created2019-10-04T12:40:57Z
dc.date.issued2019-08-15
dc.identifierJournal Of Translational Medicine. London: Bmc, v. 17, n. 1, 1 p., 2019.
dc.identifierhttp://hdl.handle.net/11449/186076
dc.identifierWOS:000482649700079
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5367128
dc.languageeng
dc.publisherBmc
dc.relationJournal Of Translational Medicine
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.titleEffect of treatment with a new nitric oxide donor, a hybrid derived from resveratrol and furoxan (E)-4-(4-(4-methoxystyryl)phenoxy)-3-methyl-1,2,5-oxadiazole-2-oxide, on priapism in sickle cell mouse and nitric oxide-deficient mouse
dc.typeOtros


Este ítem pertenece a la siguiente institución